Skip to content
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
The American Society of Oncology (ASCO) 2020 Annual Meeting was held virtually this year due to the ongoing COVID-19 pandemic. Although the meeting was virtual, the programme was full of the latest data, ongoing controversies in the field and updates on potential new treatments for cancer.
Hot topics at this year’s meeting included immunotherapy, COVID-19 and cancer, developmental therapeutics and care delivery. Data were presented from the latest clinical trials including ADAURA, JAVELIN , E2108 and KEYNOTE-177.
Immunotherapy
Immunotherapy offers patients and physicians a wider plethora of options and is becoming increasingly widespread in cancer treatment.
Speaking to leading experts, we got the latest on this type of therapy.
EXPLORE HERE
Clinical trial updates
With data constantly being produced and changing, it’s essential to keep up to date
ASCO 2020 gave us the latest data from cutting-edge research.
EXPLORE HERE
